Cite

HARVARD Citation

    Bruce, I. et al. (n.d.). OP0186 5-Year Organ Damage Accrual and Safety in Patients with Sle Treated with Belimumab Plus Standard of Care. Annals of the rheumatic diseases. p. 142. [Online]. 
  
Back to record